Rising Biosciences (Rising Biosciences) EBITDA Margin % : 0.00% (As of . 20)

View and export this data going back to . Start your Free Trial

What is Rising Biosciences EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Rising Biosciences's EBITDA for the three months ended in . 20 was $0.00 Mil. Rising Biosciences's Revenue for the three months ended in . 20 was $0.00 Mil. Therefore, Rising Biosciences's EBITDA margin for the quarter that ended in . 20 was 0.00%.

Rising Biosciences EBITDA Margin % Historical Data

The historical data trend for Rising Biosciences's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rising Biosciences EBITDA Margin % Chart

Rising Biosciences Annual Data

Trend

EBITDA Margin %

Rising Biosciences Quarterly Data

EBITDA Margin %

Competitive Comparison of Rising Biosciences's EBITDA Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Rising Biosciences's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Rising Biosciences's EBITDA Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Rising Biosciences's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Rising Biosciences's EBITDA Margin % falls into.

Rising Biosciences EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Rising Biosciences's EBITDA Margin % for the fiscal year that ended in . 20 is calculated as

EBITDA Margin %	=	EBITDA (A: . 20 )	/	Revenue (A: . 20 )
	=		/
	=	%

Rising Biosciences's EBITDA Margin % for the quarter that ended in . 20 is calculated as

EBITDA Margin %	=	EBITDA (Q: . 20 )	/	Revenue (Q: . 20 )
	=		/
	=	%

Rising Biosciences (GREY:RBII) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Rising Biosciences EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Rising Biosciences's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Rising Biosciences (Rising Biosciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Rising Biosciences Inc (GREY:RBII) » Definitions » EBITDA Margin %

Traded in Other Exchanges

N/A

Address

1180 Cleveland Road, Sandusky, OH, USA, 44870

Website

http://www.risingbiosciences.com

Rising Biosciences Inc is a United States-based company engaged in research and development activities. It is focused on oral and topical cannabis and non-cannabis based pharmaceuticals. The company seeks to address the market demand for the treatment of the danger of opiates, whose long-term effects can include liver damage, addiction and brain damage due to hypoxia, resulting from respiratory depression, among other complications.